In a separate study analyzing patients with primary and early relapsed HBV-associated HCC, researchers found that conventional M1/M2 classification markers (FCGR3A for M1, CD163 for M2) failed to clearly distinguish macrophage polarization states [102]. Here, CD163 is linked to hepatocellular carcinoma.